Form: EFFECT

Notice of Effectiveness

May 5, 2025

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

Notice of Effectiveness

Effectiveness Date: May 5, 2025
Accession Number: 0001213900-25-038970
Submission Type: POS AM
CIK: 0001894525
Company Name: Apimeds Pharmaceuticals US, Inc.
File Number: 333-282324